DA AN Gene Co.,Ltd. Of Sun Yat-Sen University (002030) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

DA AN Gene Co.,Ltd. Of Sun Yat-Sen University Company Snapshot

Business Description:

DA AN Gene Co.,Ltd. Of Sun Yat-Sen University operates in the Diagnostic substances sector. Da An Gene Co., Ltd. of Sun Yat-Sen University is principally engaged in the manufacture and sale of biological products. The Company conducts research, development and application of fluorescence polymerase chain reaction (PRC) detection technology, as well as manufacture of fluorescence PRC detection reagents and relevant medical equipment, which are applied in detection of hepatitis, tumors, venereal diseases, pneumonia and hereditary diseases, among others. The Company also offers clinical detecting services. The Company operates its businesses primarily in domestic markets. In our complete report available for purchase the company is compared to: Biosino Bio-Technology And Science Incorporation, Anhui Anke Biotechnology (Group) Company., Limited and Beihai Gofar Marine Biological Industry.

DA AN Gene Co.,Ltd. Of Sun Yat-Sen University

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 8.90
(Figures in Chinese Renmimbi)

1 Week	3.4%	13 Weeks	7.4%

4 Weeks	-13.5%	52 Weeks	-22.0%

DA AN Gene Co.,Ltd. Of Sun Yat-Sen University Key Data:

Ticker:	002030	Country:	CHINA

Exchanges:	SZN	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	369,968,000 (Year Ending Jan 2011).	Employees:	512

Currency:	Chinese Renmimbi	Market Cap:	3,085,682,688

Fiscal Yr Ends:	December	Shares Outstanding:	346,705,920

Share Type:	A Shares	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.